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Background: Both aortic valve stenosis and aortic stiffness are moderators of arterio
ventricular coupling and independent predictors of cardiovascular morbidity and mortality.
Studies on the effect of transcatheter aortic valve implantation (TAVI) on aortic functional
properties are limited. We performed a study to investigate the possible short-term changes in
aortic stiffness and other aortic functional properties after TAVI in older patients.
Methods: TAVI Care&Cure is an observational ongoing study including consecutive
patients undergoing a TAVI procedure. Central and peripheral hemodynamic measurements
were measured non invasively 1 day before (T-1) and 1 day after (T+1) TAVI using a
validated oscillometric method using a brachial cuff (Mobil-O-Graph).
Results: 40 patients were included. Mean aortic valve area at baseline was 0.76±0.24 cm2.
Indices of severity of aortic valve stenosis improved signiﬁcantly. Systolic blood pressure
(SBP) dropped by 8.5%, from 130.3±22.9 mmHg to 119.5±15.8 mmHg (p=0.005). Diastolic
blood pressure (DBP) dropped by 13.1% from 74.8±14.5 mmHg to 65.0±11.3 mmHg
(p<0.001). The arterial pulse wave velocity (aPWV) decreased from 12.05±1.99 m/s to
11.6±1.56 m/s (p=0.006). Patients with high aPWV at baseline showed a signiﬁcantly larger
reduction in SBP in comparison to patients with low aPWV: – 20.3 mmHg (−14.1%) vs – 3.1
mmHg (−2.6%), respectively (p=0.033). The same trend was found for the DBP: −16.2
(−20.4%) vs −4.5 mmHg (−6.3%) for high vs low aPWV at baseline (p=0.037).
Conclusion: We found short-term changes in blood pressure and aortic stiffness after TAVI.
The amplitude of the changes was the largest in patients with elevated aortic stiffness at
baseline.
Keywords: aortic valve stenosis, aortic stiffness, blood pressure levels, TAVI
Introduction
Aortic valve stenosis (AoS) is a common degenerative disease in older persons and
associated with poor prognosis.1,2 AoS should not only be considered a valvular
disease, but also an atherosclerotic like process leading to compromised systemic
arterial compliance.3–5 Arterial stiffness has emerged as an independent predictor of
cardiovascular risk and mortality.2,6
AoS and reduced systemic arterial compliance jointly contribute to the increase
of the left ventricular afterload affecting the left ventricular function and ventricular
remodeling7. Both are moderators of the arterio ventricular coupling, which can be
considered as a determinant of cardiovascular system performance.8 Therefore,
structural changes of one component (ie, restore normal ﬂow patterns of the aortic
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valve by replacing the degenerated valve) could have an
effect on other components, such as aortic stiffness.
Previous studies have investigated changes in systolic
blood pressure (SBP) and diastolic blood pressure (DBP)
as well as aortic stiffness after surgical aortic valve repla-
cement (SAVR),9–12 and one study observed improvement
of aortic distensibility.11 At present, there is little and
conﬂicting information on the short-term aortic functional
properties after transcatheter aortic valve implantation
(TAVI).12–14 The objective of this study was to assess the
effect of TAVI on aortic stiffness and blood pressure levels
shortly after TAVI.
Methods
Study population
The study population consists of 40 consecutive patients
with severe symptomatic AoS undergoing TAVI between
May and August 2017. All patients were accepted for
TAVI following the multidisciplinary Heart Team that
included interventional cardiologists, cardiac surgeons,
anesthetists and geriatricians.15
The medical Ethics Committee of the Erasmus Medical
center reviewed the study (MEC-2014-277), and since this
study was not subjected to the Dutch Medical Research
Involving Human Subjects Act no approval was required.
However, the study was conducted according to the
Helsinki Declaration and all patients gave written
informed consent to participate in this study after being
informed of its nature and purpose. There were no speciﬁc
exclusion criteria.
Prior to TAVI, patients were seen in the cardiology
outpatient clinic. Baseline cardiology assessment included
a full medical history including inventory of cardiovascu-
lar risk factors and determining symptoms using the New
York Heart Association (NYHA) classiﬁcation and the
Canadian Cardiovascular Society (CCS) grading of angina
pectoris, physical examination and electrocardiogram
(ECG). Further cardiologic examination included echocar-
diography, coronary angiography and multislice computed
tomography (MSCT) to address the aortic valve and arter-
ial tree and determine technical suitability for TAVI and
access site.16,17
Hemodynamics
Hemodynamic measurements consisted of the measurements
of SBP and DBP (mmHg), mean arterial pressure (mmHg),
pulse pressure (mmHg), heart rate (bpm), stroke volume
(mL), cardiac output (l/min), cardiac index (l/m*1/m), aug-
mentation index (%), peripheral vascular resistance
(s*mmHg/mL) and aortic pulse wave velocity (aPWV)
(m/s).2 aPWVis the gold standard assessment tool for arterial
stiffness, providing information about functional elastic
property and structural unity of the vessel wall.18–22
Measurements were performed the day before (T-1) and the
day after (T+1) using the non invasive Mobil-O-Graph
(Mobil-O-Graph 24h PWA Monitor, I.E.M. GmbH,
Stolberg, Germany). This electronic blood pressure oscillo-
metric monitoring system uses a simple upper arm cuff and
has speciﬁc validated software to calculate the aPWVand the
other hemodynamic parameters described above.23
Hemodynamic measurements on T-1 and T+1 were taken
in the morning after 10 mins resting in the supine position.
Echocardiography
All patients underwent a two-dimensional echocardiogra-
phy and Doppler study before the procedure and before
hospital discharge according to standard methods.24
Ejections fraction (%), peak velocity of the aortic valve
(m/S) and both the peak and mean transvalvular gradient
of the aortic valve (mmHg) were assessed using transthor-
acic echocardiography.
TAVI procedure
TAVI was performed either under general or local anesthe-
sia following the decision of the multi disciplinary heart
team. General anesthesia was used in 2 patients and the
other 38 patients received local anesthesia. The transfe-
moral arterial approach was used for 39 patients and 1
patient was surgically accessed through the axillary artery.
Patients were admitted to the intensive coronary care unit
for monitoring up to a minimum of 4 hrs. Perioperative,
there were no procedural standard medication alterations.
Statistical analysis
Categorical variables are presented as numbers and corre-
sponding percentages. Continuous variables are expressed
as means ± SD or median values with corresponding IQRs.
Differences between groups (one group examining vari-
ables before and after TAVI, the other group comparing
patients with low and high aPWV at baseline) were com-
pared with the paired t-test and the independent t-test or its
non parametric equivalents, respectively. Spearman’s cor-
relation coefﬁcients were used to test the correlation
between variables.
Goudzwaard et al Dovepress
submit your manuscript | www.dovepress.com
DovePress
Clinical Interventions in Aging 2019:141380
 
Cl
in
ica
l I
nt
er
ve
nt
io
ns
 in
 A
gi
ng
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
14
5.
5.
17
6.
8 
on
 2
2-
Au
g-
20
19
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Furthermore, we performed analyses stratiﬁed for cate-
gories of aortic stiffness. Participants were divided as
having low or high aortic stiffness based on the baseline
median aPWV value (11.9 m/s). We performed univariate
analysis within the two groups of low and high aPWV as
ﬁxed factor and the hemodynamic value of interest as the
dependent value. Models were adjusted for age, and the
variable of interest at T-1 (ie, SBP at T-1 was included in
models investigating the change of SBP levels). Data were
analyzed with statistic program IBM Statistical Package
for Social Science for Windows version 21 (SPSS).
p-value of ≤0.05 was considered statistically signiﬁcant.
Results
Baseline characteristics
The baseline characteristics are summarized in Table 1.
Mean age was 80.1±7.6 years, 42.5%were women. The
prevalence of hypertension was 61.5%. Mean SBP was
130.3±22.9 mmHg and the mean pulse wave velocity was
12.1±1.9 m/s. The mean aortic valve area was 0.76
±0.24 cm.
Echocardiographic and hemodynamic
changes after TAVI
Table 2 shows the echocardiographic and hemodynamic
changes on T-1 and T+1. The aPWV and augmentation
index and peripheral vascular resistance decreased signiﬁ-
cantly (p=0.006, p<0.002 and p<0.001).
The aPWV measured before TAVI (T-1) correlated
with the change in SBP (Spearman’s rho=−0.603,
p<0.001), DBP (Spearman’s rho =−0.477, p=0.002), per-
ipheral vascular resistance (Spearman’s rho=−0.338,
p=0.033) and aPWV (Spearman’s rho=−0.583, p<0.001).
The aPWV measured before TAVI (T-1) did not correlate
with the change in augmentation index (Spearman’s rho =
−0.282, p=0.078) (Figure 1). Patients were subsequently
divided into two groups (low and high aortic stiffness)
according to the median value of aPWV at baseline.
Patients with high aPWV at baseline showed a signiﬁ-
cantly larger reduction in SBP in comparison to patients
with low aPWV: – 20.3 mmHg (−14.1%) vs – 3.1 mmHg
(−2.6%), respectively (p=0.033). A similar trend was
found when analyzing the changes of the DBP: −16.2
mmHg (−20.4%) vs −4.5 mmHg (−6.3%) for high vs
low aPWV at baseline (p=0.037). Cardiac output increased
in the high aPWV group with 4.6 mL/min (+4.5%) and
0.78 mL/min (+16%) in the low aPWV baseline group,
although not signiﬁcant (p=0.33). The change in augmen-
tation index, peripheral resistance and aPWV differed
between the two groups with low and high aPWV mea-
sured before TAVI (T-1), but not signiﬁcantly (p=0.993;
p=0.430; p=0.169 resp.) (Figure 2).
Discussion
In this study, we found short-term decrease in blood pres-
sure levels and aortic stiffness after TAVI in older patients.
The amplitude of the changes was largest in patients with
elevated aortic stiffness at baseline.
The impact of aortic valve replacement on hemody-
namic parameters such as aortic stiffness has been pre-
viously investigated in relatively small groups of patients
receiving both SAVR and TAVI and results are controver-
sial. In a study investigating only SAVR patients, the aortic
distensibility showed progressive improvement up to 1 year
after the intervention. This study also showed that blood
pressure signiﬁcantly dropped up to 3 weeks after SAVR.11
Another study compared the effects of both SAVR and
Table 1 Demographic and clinical data (n=40)
Age (years ± SD) 80.1±7.6
Women (%) 42.5
BMI (kg/m2) 26.8±3.6
Cardiovascular risk factors
Hypertension (%) 61.5
Dyslipidemia (%) 59.0
Diabetes mellitus (%) 27.5
Current smoker (%) 5.1
Family history of CAD (%) 30.8
Medication
Β-blockers (%) 20.0
ACE/ARB (%) 27.5
Calcium antagonists (%) 22.5
Nitrates (%) 7.5
Diuretics (%) 55.0
Comorbidities
Coronary artery disease (%) 35.0
Previous stroke (%) 30.8
COPD (%) 26.6
Renal disease (%) 30.8
Symptoms
NYHA Class 3 or 4 (%) 50.0
Angina CCS classiﬁcation 3 or 4 (%) 0.0
Vertigo (%) 36.8
Abbreviations: BMI, body mass index; ACE, angiotensin-converting enzyme inhi-
bitor; ARB, angiotensin II receptor blockers; NYHA, New York Heart Association;
CCS, Canadian Cardiovascular Society; CAD, coronary artery disease; COPD,
Chronic Obstructive Pulmonary Disease.
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TAVI on aortic stiffness and found that treatment of severe
AoS by SAVR, but not with TAVI, was associated with an
increase in aortic stiffness at 6 months.25 Conversely, other
authors found no signiﬁcant change in aortic stiffness after
replacing the aortic valve in both SAVR and TAVI
patients.12
In a population of 23 patients treated with TAVI, a
signiﬁcant decrease of aortic compliance and arterial ela-
stance was found.13 On the contrary, in a slightly larger
population of 30 patients, there was no change found in
the elasticity of the aorta after TAVI.14
In our study, we found a short-term decrease in blood
pressure levels and aortic stiffness after TAVI. The short-term
decrease in hemodynamic measurements after TAVI and the
large amplitude in patients with high aPWV might be a
consequence of the changes in the arterio ventricular coupling
due to the replacement of the degenerated aortic valve.
We also found that for the total study population car-
diac output and cardiac index increased signiﬁcantly after
TAVI with an also signiﬁcant decrease in augmentation
index and peripheral vascular resistance. When we divided
patients into two groups of low and high aPWV before
TAVI, we could not ﬁnd a signiﬁcant difference between
the two groups of low and high aPWVat baseline. It could
be speculated that the effect of the changed arterioventri-
cular coupling has a similar effect on these hemodynamic
variables, whether or not patients have low or high aPWV
values before TAVI.
Since AoS is no longer considered as an isolated aortic
valve disease but rather a complex disease in which the
central actors are the left ventricle (ability to adapt to the
increased afterload), the valve (severity of valvular
obstruction) and the vascular system (reduced arterial
compliance),26 a change in one of the components could
well lead to a change in one of the other determinants.
AoS leads to increased left ventricular afterload, effect-
ing left ventricular function and ventricular remodeling,7
which are determinants of impaired aortic stiffness.18
The correlation of aortic stiffness and severity of AoS
has been investigated,12,27,28 and although controversial,
the hypothesis that if aortic stiffness and severity of AoS
are correlated by interacting in the arterio ventricular cou-
pling, one could assume that restoring hemodynamic para-
meters of the aortic valve, the aortic stiffness will
decrease. Another hypothesis is that the turbulent ﬂow
across the stenotic aortic valve may damage aortic root
endothelium, leading to alterations of the elastic properties
of the aorta and that by replacing the degenerated valve,
which leads to recovery of the aortic root endothelium,
vascular elasticity can improve.11,29 Since we measured
aortic stiffness very shortly after TAVI, this theory will
presumably not be applicable in the present study, since
Table 2 Echocardiographic and hemodynamic changes at baseline and after TAVI
Variable T-1 T+1 P-value
Echocardiographic measurements
Ejection fraction (%) 55.4±12.7 55.6±11.9 0.576
Peak AoV (m/s) 4.1±0.7 2.1±0.4 <0.0001
Peak transvalvular gradient (mmHg) 68.2±23.2 17.0±7.9 <0.001
Mean transvalvular gradient (mmHg) 41.5±15.7 9.5±5.3 <0.001
Hemodynamic measurements
Systolic blood pressure (mmHg) 130.3±22.9 119.5±15.8 0.005
Diastolic blood pressure (mmHg) 74.8±14.5 65.0±11.3 <0.001
Mean arterial pressure (mmHg) 100.1±17.0 89.9±12.1 0.001
Pulse pressure (mmHg) 55.6±16.1 54.5±12.5 0.64
Heart rate (bpm) 66.6±13.0 70.3±10.2 0.081
Stroke volume (mL) 71.9±12.5 75.8±18.1 0.25
Cardiac output (L/min) 4.7±0.9 5.3±1.1 0.019
Cardiac index (L/m*1/m2) 2.5±0.6 2.8±0.6 0.023
Augmentation index (%) 27.7±13.9 17.6±13.6 0.002
Aortic pulse wave velocity (m/s) 12.1±1.9 11.6±1.6 0.006
Peripheral vascular resistance (s*mmHg/mL) 1.31±0.3 1.07±0.2 <0.001
Notes: T-1: 1 day before TAVI. T+1: 1 day after TAVI.
Abbreviation: AoV, aortic valve.
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the time span seems to be too short to already see the
effect of changed endothelium function on aortic stiffness.
Further research could be focusing on the role of the
impact of changes in aortic stiffness and hemodynamic
parameters on mortality and other clinical outcomes. In
an aged and multimorbid population, speciﬁc prognostic
tools would be helpful in further clinical decision-mak-
ing on whether or not to treat patients. The valvulo
arterial impedance, for example, a parameter that incor-
porates both arterial impedance and valve severity,7,30
3has shown to have predictive value for outcome in
medically managed aortic stenosis patients, but also
has been shown to be associated with increased long-
term mortality.1
The present study has some limitations. First, we
included a relatively small number of patients; therefore,
the results need to be replicated in a larger group of
patients. Second, there were no standard medication
changes in antihypertensive drug regiments; however,
changes in drug treatment during the procedure were not
registered. Since the measurements of the hemodynamic
parameters were only 1 day after TAVI, the risk of mea-
suring the effect of changes in antihypertensive drug regi-
ments is probably limited.
Third, in this study we have not included inﬂammatory
markers in our analysis. Previous studies have described
signiﬁcant correlations between inﬂammatory markers and
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Figure 1 Changes in hemodynamic measurements correlated to baseline aPWV. Change in systolic blood pressure (A), diastolic blood pressure (B), cardiac output (C),
augmentation index (D), peripheral resistance (E), aPWV (F) according to aPWV at baseline.
Abbreviation: aPWV, aortic pulse wave velocity.
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severity of arterial stiffness, in a wide variety of patient
populations including those with the same comorbidities
as our study population.32
In conclusion, we found a short-term decrease in blood
pressure levels and aortic stiffness after TAVI. The ampli-
tude of these changes was larger in patients with elevated
aortic stiffness at baseline.
Highlights
● Aortic valve stenosis and aortic stiffness are both mod-
erators of atrioventricular coupling.
● We observed a decrease in blood pressure levels
and aortic stiffness in the short-term period after
TAVI.
● The amplitude of these changes was larger in patients
with elevated aortic stiffness at baseline.
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Figure 2 Percentual changes in hemodynamic measurements. Percentual change in systolic blood pressure (A), diastolic blood pressure (B), cardiac output (C),
augmentation index (D), peripheral resistance (E), aPWV (F) when patients are divided according to high and low aPWV at baseline.
Notes: (A) SBP: aPWV low vs aPWV high (p=0.033). (B) DBP: aPWV low vs aPWV high (p=0.037). *p < 0.05.
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; CO, cardiac output; aPWV, aortic pulse wave velocity.
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